Adoptive immunotherapy involves the ex vivo manipulation and expansion of lymphocytes to treat cancer. These lymphocytes, or effector cells, are “adoptively” transferred into the recipient and may be infused alone or as part of a regimen that includes chemotherapy, radiation therapy, exogenous cytokines and/or other biologic agents (e.g., antibodies) designed to enhance their survival and killing potential in vivo.
|Original language||English (US)|
|Title of host publication||Innate Immune Regulation and Cancer Immunotherapy|
|Publisher||Springer New York|
|Number of pages||27|
|State||Published - Jan 1 2012|
ASJC Scopus subject areas